These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 27993854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.
    Pfaller MA, Huband MD, Rhomberg PR, Flamm RK.
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223386
    [Abstract] [Full Text] [Related]

  • 3. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
    Huband MD, Pfaller MA, Shortridge D, Flamm RK.
    J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
    [Abstract] [Full Text] [Related]

  • 4. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
    Pfaller MA, Huband MD, Shortridge D, Flamm RK.
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378719
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ, Arhin FF, Moeck G, Lynch TF, Sahm DF.
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [Abstract] [Full Text] [Related]

  • 6. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020.
    Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR, SMART Program Study Group.
    Int J Antimicrob Agents; 2023 Apr; 61(4):106745. PubMed ID: 36758774
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Pfaller MA, Huband MD, Shortridge D, Flamm RK.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32071045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program.
    McCurdy SP, Jones RN, Mendes RE, Puttagunta S, Dunne MW.
    Antimicrob Agents Chemother; 2015 Aug 21; 59(8):5007-9. PubMed ID: 25987636
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
    Sader HS, Flamm RK, Jones RN.
    Antimicrob Agents Chemother; 2013 Jul 21; 57(7):3178-81. PubMed ID: 23629712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
    Mendes RE, Sader HS, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2015 Mar 21; 59(3):1811-4. PubMed ID: 25561335
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
    Macone AB, Caruso BK, Leahy RG, Donatelli J, Weir S, Draper MP, Tanaka SK, Levy SB.
    Antimicrob Agents Chemother; 2014 Mar 21; 58(2):1127-35. PubMed ID: 24295985
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ, Flamm RK, Sader HS, Jones RN.
    Int J Antimicrob Agents; 2014 Apr 21; 43(4):323-7. PubMed ID: 24411474
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018.
    Dong D, Zheng Y, Chen Q, Guo Y, Yang Y, Wu S, Zhu D, Deng D, Bradford PA, Reinhart H, Hu F.
    Eur J Clin Microbiol Infect Dis; 2020 Aug 21; 39(8):1559-1572. PubMed ID: 32356026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.